Table 2.
Dkk‐3 expression † | CD31 expression † | |||||||
---|---|---|---|---|---|---|---|---|
Patients n = 154 | <25 vessels n | >25 vessels n | P‐values ‡ | Patients n = 108 | <25 vessels n | >25 vessels n | P‐values ‡ | |
Age at diagnosis | ||||||||
≤ 67 | 78 | 36 | 42 | 0.476 | 57 | 14 | 43 | 0.108 |
> 67 | 76 | 32 | 43 | 51 | 18 | 33 | ||
Sex | ||||||||
Male | 83 | 39 | 44 | 56 | 17 | 39 | ||
Female | 72 | 29 | 41 | 0.370 | 52 | 17 | 35 | 0.822 |
Differentiation | ||||||||
Well | 19 | 5 | 14 | 17 | 4 | 13 | ||
Moderate | 93 | 44 | 49 | 0.006 | 65 | 20 | 45 | 0.482 |
Poor | 42 | 29 | 13 | 26 | 9 | 17 | ||
UICC stage | ||||||||
I, II | 24 | 15 | 9 | 53 | 9 | 44 | ||
III, IV | 94 | 39 | 55 | 0.107 | 19 | 5 | 14 | 0.489 |
Unknown § | 36 | 36 |
Number of positive vessels per high power field.
χ2‐test.
Not included in statistical analysis.